Literature DB >> 20718622

Boosting in athletes with high-level spinal cord injury: knowledge, incidence and attitudes of athletes in paralympic sport.

Yagesh Bhambhani1, Jennifer Mactavish, Sharon Warren, Walter R Thompson, Anthony Webborn, Elizabeth Bressan, Marco Tuilo De Mello, Sean Tweedy, Laurie Malone, Kennet Frojd, Peter Van De Vliet, Yves Vanlandewijck.   

Abstract

UNLABELLED: Autonomic dysreflexia (AD) is unique to individuals with spinal injuries (SCI) at T6 or above and can be voluntarily induced. Although AD improves wheelchair racing performance in some athletes, it also elicits exaggerated blood pressure, which could be dangerous. The International Paralympic Committee considers AD doping and banned its use.
PURPOSE: The purpose of this study is to evaluate AD knowledge, incidence and attitudes (KIA) of Paralympians with SCI.
METHODS: An existing questionnaire was modified to include questions of AD KIA, validated by three experts and piloted with a small sample. It was administered on-line, mailed to members of a scientific network and distributed during the Beijing Paralympic Games. Fisher Exact test was used to evaluate differences across gender, injury and education.
RESULTS: Of 99 participants, 54.5% had previously heard of AD while 39.4% were unaware; 16.7%, all males, had used AD to enhance performance. Participants reported that AD was (1) useful for middle (78.6%) and long distance (71.4%), marathon (64.3%) and wheelchair rugby (64.3%); (2) somewhat dangerous (48.9%), dangerous (21.3%) or very dangerous (25.5%) to health. Results were not influenced by age, injury level or injury duration.
CONCLUSIONS: Findings indicate the need for educational programmes directed towards enhancing the AD knowledge of rehabilitation professionals, coaches and trainers working with SCI individuals.

Entities:  

Mesh:

Year:  2010        PMID: 20718622     DOI: 10.3109/09638288.2010.505678

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  6 in total

Review 1.  Boosting in Elite Athletes with Spinal Cord Injury: A Critical Review of Physiology and Testing Procedures.

Authors:  Cameron M Gee; Christopher R West; Andrei V Krassioukov
Journal:  Sports Med       Date:  2015-08       Impact factor: 11.136

2.  Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and Lows: Management of Blood Pressure, Sweating, and Temperature Dysfunction.

Authors:  Andrei Krassioukov; Todd A Linsenmeyer; Lisa A Beck; Stacy Elliott; Peter Gorman; Steven Kirshblum; Lawrence Vogel; Jill Wecht; Sarah Clay
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

3.  International Standards to document Autonomic Function following SCI (ISAFSCI): Second Edition.

Authors:  Jill M Wecht; Andrei V Krassioukov; Maralee Alexander; John P Handrakis; Stephen L McKenna; Michael Kennelly; Michele Trbovich; Fin Biering-Sorensen; Stephen Burns; Stacy L Elliott; Daniel Graves; James Hamer; Klaus Krogh; Todd A Linsenmeyer; Nan Liu; Ellen Merete Hagen; Aaron A Phillips; Jean-Gabriel Previnaire; Gianna M Rodriguez; Chloe Slocum; James R Wilson
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

Review 4.  "Boosting" in Paralympic athletes with spinal cord injury: doping without drugs.

Authors:  Filomena Mazzeo; Stefania Santamaria; Alessandro Iavarone
Journal:  Funct Neurol       Date:  2015 Apr-Jun

5.  [Formula: see text]  [Formula: see text]  [Formula: see text] [Formula: see text]Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and Lows.

Authors:  Andrei Krassioukov; Todd A Linsenmeyer; Lisa A Beck; Stacy Elliott; Peter Gorman; Steven Kirshblum; Lawrence Vogel; Jill Wecht; Sarah Clay
Journal:  J Spinal Cord Med       Date:  2021-07       Impact factor: 2.040

6.  Are tetraplegic handbikers going to disappear from team relay in para-cycling?

Authors:  Thierry Weissland; Pierre-Marie Leprêtre
Journal:  Front Physiol       Date:  2013-04-09       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.